Accelerating Innovation from Discovery to Development 03/03/2025 Healthcare Access to innovation Innovative drugs Personalized medicine Advanced therapies Pharmaron accelerates drug discovery by transforming scientific breakthroughs into therapies, using advanced... Partners
Integra Therapeutics, first company to move into Advanced Therapies Platform at SJD Barce... 24/02/2025 Healthcare Innovative drugs Personalized medicine Advanced therapies Integra Therapeutics has developed the FiCAT gene-writing platform to develop cell therapies for autoimmune and oncology... Partners - Integra Therapeutics S.L.
Driving innovation in advanced therapies 24/02/2025 Healthcare Access to innovation Innovative drugs Personalized medicine To contribute to the democratization of access to new cell therapies, Klinea works on various initiatives. The project... Partners - Klinea Biotech & Pharma Engineering
Vaccines, gene-editing-based therapies, and immunotherapies will transform the current lan... 04/02/2025 Healthcare Access to innovation Drug discovery Innovative drugs Personalized medicine Advanced therapies Biotechnology has radically changed the treatment of many types of tumors, evolving from highly aggressive and non... AseBio - BATEA ONCOLOGY S.L.
Vaccines, gene-editing-based therapies, and immunotherapies will transform the current lan... 04/02/2025 BATEA ONCOLOGY S.L. It will also be necessary to develop therapies with fewer side effects, allowing the combination of different treatments... AseBio - BATEA ONCOLOGY S.L.
Integra Therapeutics part of Spanish Government presentation of ‘HispanIA 2040’ as an AI f... 28/01/2025 Healthcare Access to innovation Personalized medicine Gene editing HispanIA 2040 is a strategic study promoted by the Spanish National Office of Foresight and Strategy, compiled by 12... Partners - Integra Therapeutics S.L.
Key Trends in Sepsis for 2025 07/01/2025 Healthcare Personalized medicine Advanced therapies In Spain, the incidence of sepsis is 212 cases per 100,000 inhabitants per year, with a mortality rate ranging from 15%... Partners - VIVA IN VITRO
Nanobots Therapeutics advances its development after securing the first million in its see... 18/12/2024 Healthcare Innovative drugs Personalized medicine Financing The startup successfully completed the first stage of its seed investment round, raising €960,000 in private capital. Partners - NANOBOTS THERAPEUTICS
VIVEbiotech Secures Growth Investment from Ampersand Capital Partners to Expand Lentivira... 04/12/2024 Healthcare Personalized medicine VIVEbiotech, a company specializing in lentiviral vectors for gene and cell therapies, has received an investment from... Partners - VIVEbiotech
"ABLE Human Motion was created almost 6 years ago with the vision of democratising robot... 24/10/2024 Healthcare Access to innovation Personalized medicine Financing Talento Corporate Partners - GENESIS Biomed
